Inici › Glioma › Ohio › Columbus
Assaigs clínics de Glioma a Columbus, OH
15 estudis de Glioma busquen participants en centres de Columbus i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
ReclutantFase 1/2
- Nationwide Children's Hospital, Columbus
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
ReclutantFase 2
- Ohio State University, Columbus
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
ReclutantFase 2
- Nationwide Children's Hospital, Columbus
Targeted Pediatric High-Grade Glioma Therapy
ReclutantEstudi observacional
- Nationwide Children's Hospital, Columbus
Study of Olutasidenib and Temozolomide in HGG
ReclutantFase 2
- Nationwide Children's Hospital, Columbus
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
ReclutantFase 2
- Nationwide Children's Hospital, Columbus
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
ReclutantFase 2
- The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
Reclutant
- Ohio State University Medical Center, Columbus
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
ReclutantFase 1/2
- Nationwide Children's Hospital, Columbus
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
ReclutantFase 1 inicialVoluntaris sans benvinguts
- Nationwide Children's Hospital, Columbus
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
ReclutantFase 2
- Nationwide Children's Hospital, Columbus
Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas
ReclutantFase 1
- Ohio State University Comprehensive Cancer Center, Columbus
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
ReclutantFase 1/2
- Ohio State University Comprehensive Cancer Center, Columbus
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
ReclutantFase 1 inicial
- Nationwide Children's Hospital, Columbus
Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells
ReclutantFase 1
- Nationwide Children's Hospital, Columbus
Assaigs de Glioma en altres ciutats
- New York City, NY25 estudis
- Houston, TX23 estudis
- Boston, MA20 estudis
- Washington, DC19 estudis
- Philadelphia, PA16 estudis
- Miami, FL15 estudis
- San Francisco, CA14 estudis
- Chicago, IL13 estudis
- Durham, NC12 estudis
- Seattle, WA11 estudis
- Los Angeles, CA10 estudis
- St. Louis, MO10 estudis
Altres estudis a Columbus
- Càncer de pulmó de cèl·lules no petites56 estudis
- Càncer de mama39 estudis
- Càncer d'ovari39 estudis
- Càncer (tots els tipus)38 estudis
- Càncer de pulmó37 estudis
- Leucèmia mieloide aguda35 estudis
- Leucèmia limfàtica crònica28 estudis
- Càncer metastàtic27 estudis
- Càncer d'endometri25 estudis
- Càncer colorrectal24 estudis
- Càncer de pròstata24 estudis
- Mieloma múltiple24 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.